Extra-gain of HER2-positive cases through HER2 reassessment in primary and metastatic sites in advanced gastric cancer with initially HER2-negative primary tumours: Results of GASTric cancer HER2 reassessment study 1 (GASTHER1)-Reference-Cited by-同舟云学术

Extra-gain of HER2-positive cases through HER2 reassessment in primary and metastatic sites in advanced gastric cancer with initially HER2-negative primary tumours: Results of GASTric cancer HER2 reassessment study 1 (GASTHER1)

Published:2016-01 Issue: Volume:53 Page:42-50
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Park Sook Ryun,Park Young Soo,Ryu Min-Hee^ORCID,Ryoo Baek-Yeol,Woo Chang Gok^ORCID,Jung Hwoon-Yong^ORCID,Lee Jeong Hoon,Lee Gin Hyug,Kang Yoon-Koo

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference26 articles.

1. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer;Slamon;Science,1989

2. Trastuzumab–mechanism of action and use in clinical practice;Hudis;N Engl J Med,2007

3. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial;Bang;Lancet,2010

4. Results and implications of the Trastuzumab for Gastric Cancer (ToGA) trial;Yoon;Clin Invest,2011

5. Assessment of a HER2 scoring system for gastric cancer: results from a validation study;Hofmann;Histopathology,2008

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resistance to Anti-HER2 Therapies in Gastrointestinal Malignancies;Cancers;2024-08-15

2. HER2-directed therapy following ctDNA-identified ERBB2 amplification in patients with advanced gastroesophageal cancer: exploration of real-world outcomes;ESMO Gastrointestinal Oncology;2024-06

3. Targeting HER2 in Gastroesophageal Adenocarcinoma: Molecular Features and Updates in Clinical Practice;International Journal of Molecular Sciences;2024-03-30

4. HER2-Positive Gastric Cancer and Antibody Treatment: State of the Art and Future Developments;Cancers;2024-03-29

5. Impact of HER2-Low Status in Metastatic Gastric Cancer: A Real-World Retrospective Cohort Study;Oncology;2024-02-14